Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Drolet

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
L'Union Medicale Du Canada|May 1, 1983
[Adjuvant therapy of cancer of the breast: where are we now?]Y Drolet
L'Union Medicale Du Canada|June 1, 1971
[Leukemic meningitis in children]P Benoit, R Raymond, Y Drolet
La Vie Medicale Au Canada Francais|March 1, 1973
[Combined chemotherapy in metastasing cancer of the breast]P D'Auteuil, Y Drolet, R Blouin
L'Union Medicale Du Canada|May 1, 1985
[In vitro sensitivity tests of clonogenic tumor cells: a review of the subject]M Bergeron, Y Drolet, J Huot
L'Union Medicale Du Canada|October 1, 1970
[Tumoral testicular infiltration in acute leukemia in complete medullary and hematologic remission: 2 cases]Y Drolet, P Fortin, E Rioux
Cancer|February 1, 1985
Erythrocyte mean corpuscular volume during cytotoxic therapy and the risk of secondary leukemiaA de Gramont, E Rioux, Y Drolet, et al.
Cancer Treatment Reports|December 1, 1984
Study of erythrocyte mean corpuscular volume during cytotoxic therapy as a predictive parameter of the risk of secondary leukemia in Hodgkin's diseaseA de Gramont, E Rioux, Y Drolet, et al.
L'Union Medicale Du Canada|September 1, 1985
[Acute lymphoblastic leukemia: 13 years' experience]R Blouin, Y Drolet, A Lavoie, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|March 29, 1984
[Changes in the mean corpuscular volume during the cytotoxic treatment of cancer and risk of secondary leukemia. Preliminary results]A de Gramont, E Rioux, Y Drolet, et al.
L'Union Medicale Du Canada|November 1, 1984
[Second-line chemotherapy of ovarian cancer]A de Gramont, Y Drolet, A Lavoie, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
L'Union Medicale Du Canada|May 1, 1983
[Adjuvant therapy of cancer of the breast: where are we now?]Y Drolet
L'Union Medicale Du Canada|June 1, 1971
[Leukemic meningitis in children]P Benoit, R Raymond, Y Drolet
La Vie Medicale Au Canada Francais|March 1, 1973
[Combined chemotherapy in metastasing cancer of the breast]P D'Auteuil, Y Drolet, R Blouin
L'Union Medicale Du Canada|May 1, 1985
[In vitro sensitivity tests of clonogenic tumor cells: a review of the subject]M Bergeron, Y Drolet, J Huot
L'Union Medicale Du Canada|October 1, 1970
[Tumoral testicular infiltration in acute leukemia in complete medullary and hematologic remission: 2 cases]Y Drolet, P Fortin, E Rioux
Cancer|February 1, 1985
Erythrocyte mean corpuscular volume during cytotoxic therapy and the risk of secondary leukemiaA de Gramont, E Rioux, Y Drolet, et al.
Cancer Treatment Reports|December 1, 1984
Study of erythrocyte mean corpuscular volume during cytotoxic therapy as a predictive parameter of the risk of secondary leukemia in Hodgkin's diseaseA de Gramont, E Rioux, Y Drolet, et al.
L'Union Medicale Du Canada|September 1, 1985
[Acute lymphoblastic leukemia: 13 years' experience]R Blouin, Y Drolet, A Lavoie, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|March 29, 1984
[Changes in the mean corpuscular volume during the cytotoxic treatment of cancer and risk of secondary leukemia. Preliminary results]A de Gramont, E Rioux, Y Drolet, et al.
L'Union Medicale Du Canada|November 1, 1984
[Second-line chemotherapy of ovarian cancer]A de Gramont, Y Drolet, A Lavoie, et al.
Pageof 2